Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Mexoryl SX Market

ID: MRFR/CnM/31620-HCR
111 Pages
Chitranshi Jaiswal
Last Updated: April 06, 2026

Mexoryl SX Market Research Report: By Product Formulation (Sunscreens, Moisturizers, Makeup Products, Hair Care Products), By End User Demographics (Adults, Children, Seniors), By Distribution Channel (Online Retail, Pharmacy, Supermarkets, Specialty Stores), By Skin Type Compatibility (Oily Skin, Dry Skin, Combination Skin, Sensitive Skin), By Functionality (UV Protection, Anti-Aging, Hydration, Color Correction) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Mexoryl SX Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Chemicals and Materials, BY Product Formulation (USD Billion)
  49.     4.1.1 Sunscreens
  50.     4.1.2 Moisturizers
  51.     4.1.3 Makeup Products
  52.     4.1.4 Hair Care Products
  53.   4.2 Chemicals and Materials, BY End User Demographics (USD Billion)
  54.     4.2.1 Adults
  55.     4.2.2 Children
  56.     4.2.3 Seniors
  57.   4.3 Chemicals and Materials, BY Distribution Channel (USD Billion)
  58.     4.3.1 Online Retail
  59.     4.3.2 Pharmacy
  60.     4.3.3 Supermarkets
  61.     4.3.4 Specialty Stores
  62.   4.4 Chemicals and Materials, BY Skin Type Compatibility (USD Billion)
  63.     4.4.1 Oily Skin
  64.     4.4.2 Dry Skin
  65.     4.4.3 Combination Skin
  66.     4.4.4 Sensitive Skin
  67.   4.5 Chemicals and Materials, BY Functionality (USD Billion)
  68.     4.5.1 UV Protection
  69.     4.5.2 Anti-Aging
  70.     4.5.3 Hydration
  71.     4.5.4 Color Correction
  72.   4.6 Chemicals and Materials, BY Region (USD Billion)
  73.     4.6.1 North America
  74.       4.6.1.1 US
  75.       4.6.1.2 Canada
  76.     4.6.2 Europe
  77.       4.6.2.1 Germany
  78.       4.6.2.2 UK
  79.       4.6.2.3 France
  80.       4.6.2.4 Russia
  81.       4.6.2.5 Italy
  82.       4.6.2.6 Spain
  83.       4.6.2.7 Rest of Europe
  84.     4.6.3 APAC
  85.       4.6.3.1 China
  86.       4.6.3.2 India
  87.       4.6.3.3 Japan
  88.       4.6.3.4 South Korea
  89.       4.6.3.5 Malaysia
  90.       4.6.3.6 Thailand
  91.       4.6.3.7 Indonesia
  92.       4.6.3.8 Rest of APAC
  93.     4.6.4 South America
  94.       4.6.4.1 Brazil
  95.       4.6.4.2 Mexico
  96.       4.6.4.3 Argentina
  97.       4.6.4.4 Rest of South America
  98.     4.6.5 MEA
  99.       4.6.5.1 GCC Countries
  100.       4.6.5.2 South Africa
  101.       4.6.5.3 Rest of MEA
  102. 5 SECTION V: COMPETITIVE ANALYSIS
  103.   5.1 Competitive Landscape
  104.     5.1.1 Overview
  105.     5.1.2 Competitive Analysis
  106.     5.1.3 Market share Analysis
  107.     5.1.4 Major Growth Strategy in the Chemicals and Materials
  108.     5.1.5 Competitive Benchmarking
  109.     5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
  110.     5.1.7 Key developments and growth strategies
  111.       5.1.7.1 New Product Launch/Service Deployment
  112.       5.1.7.2 Merger & Acquisitions
  113.       5.1.7.3 Joint Ventures
  114.     5.1.8 Major Players Financial Matrix
  115.       5.1.8.1 Sales and Operating Income
  116.       5.1.8.2 Major Players R&D Expenditure. 2023
  117.   5.2 Company Profiles
  118.     5.2.1 L'Oreal (FR)
  119.       5.2.1.1 Financial Overview
  120.       5.2.1.2 Products Offered
  121.       5.2.1.3 Key Developments
  122.       5.2.1.4 SWOT Analysis
  123.       5.2.1.5 Key Strategies
  124.     5.2.2 BASF (DE)
  125.       5.2.2.1 Financial Overview
  126.       5.2.2.2 Products Offered
  127.       5.2.2.3 Key Developments
  128.       5.2.2.4 SWOT Analysis
  129.       5.2.2.5 Key Strategies
  130.     5.2.3 Galderma (CH)
  131.       5.2.3.1 Financial Overview
  132.       5.2.3.2 Products Offered
  133.       5.2.3.3 Key Developments
  134.       5.2.3.4 SWOT Analysis
  135.       5.2.3.5 Key Strategies
  136.     5.2.4 Shiseido (JP)
  137.       5.2.4.1 Financial Overview
  138.       5.2.4.2 Products Offered
  139.       5.2.4.3 Key Developments
  140.       5.2.4.4 SWOT Analysis
  141.       5.2.4.5 Key Strategies
  142.     5.2.5 Estée Lauder (US)
  143.       5.2.5.1 Financial Overview
  144.       5.2.5.2 Products Offered
  145.       5.2.5.3 Key Developments
  146.       5.2.5.4 SWOT Analysis
  147.       5.2.5.5 Key Strategies
  148.     5.2.6 Procter & Gamble (US)
  149.       5.2.6.1 Financial Overview
  150.       5.2.6.2 Products Offered
  151.       5.2.6.3 Key Developments
  152.       5.2.6.4 SWOT Analysis
  153.       5.2.6.5 Key Strategies
  154.     5.2.7 Johnson & Johnson (US)
  155.       5.2.7.1 Financial Overview
  156.       5.2.7.2 Products Offered
  157.       5.2.7.3 Key Developments
  158.       5.2.7.4 SWOT Analysis
  159.       5.2.7.5 Key Strategies
  160.     5.2.8 Unilever (GB)
  161.       5.2.8.1 Financial Overview
  162.       5.2.8.2 Products Offered
  163.       5.2.8.3 Key Developments
  164.       5.2.8.4 SWOT Analysis
  165.       5.2.8.5 Key Strategies
  166.   5.3 Appendix
  167.     5.3.1 References
  168.     5.3.2 Related Reports
  169. 6 LIST OF FIGURES
  170.   6.1 MARKET SYNOPSIS
  171.   6.2 NORTH AMERICA MARKET ANALYSIS
  172.   6.3 US MARKET ANALYSIS BY PRODUCT FORMULATION
  173.   6.4 US MARKET ANALYSIS BY END USER DEMOGRAPHICS
  174.   6.5 US MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  175.   6.6 US MARKET ANALYSIS BY SKIN TYPE COMPATIBILITY
  176.   6.7 US MARKET ANALYSIS BY FUNCTIONALITY
  177.   6.8 CANADA MARKET ANALYSIS BY PRODUCT FORMULATION
  178.   6.9 CANADA MARKET ANALYSIS BY END USER DEMOGRAPHICS
  179.   6.10 CANADA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  180.   6.11 CANADA MARKET ANALYSIS BY SKIN TYPE COMPATIBILITY
  181.   6.12 CANADA MARKET ANALYSIS BY FUNCTIONALITY
  182.   6.13 EUROPE MARKET ANALYSIS
  183.   6.14 GERMANY MARKET ANALYSIS BY PRODUCT FORMULATION
  184.   6.15 GERMANY MARKET ANALYSIS BY END USER DEMOGRAPHICS
  185.   6.16 GERMANY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  186.   6.17 GERMANY MARKET ANALYSIS BY SKIN TYPE COMPATIBILITY
  187.   6.18 GERMANY MARKET ANALYSIS BY FUNCTIONALITY
  188.   6.19 UK MARKET ANALYSIS BY PRODUCT FORMULATION
  189.   6.20 UK MARKET ANALYSIS BY END USER DEMOGRAPHICS
  190.   6.21 UK MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  191.   6.22 UK MARKET ANALYSIS BY SKIN TYPE COMPATIBILITY
  192.   6.23 UK MARKET ANALYSIS BY FUNCTIONALITY
  193.   6.24 FRANCE MARKET ANALYSIS BY PRODUCT FORMULATION
  194.   6.25 FRANCE MARKET ANALYSIS BY END USER DEMOGRAPHICS
  195.   6.26 FRANCE MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  196.   6.27 FRANCE MARKET ANALYSIS BY SKIN TYPE COMPATIBILITY
  197.   6.28 FRANCE MARKET ANALYSIS BY FUNCTIONALITY
  198.   6.29 RUSSIA MARKET ANALYSIS BY PRODUCT FORMULATION
  199.   6.30 RUSSIA MARKET ANALYSIS BY END USER DEMOGRAPHICS
  200.   6.31 RUSSIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  201.   6.32 RUSSIA MARKET ANALYSIS BY SKIN TYPE COMPATIBILITY
  202.   6.33 RUSSIA MARKET ANALYSIS BY FUNCTIONALITY
  203.   6.34 ITALY MARKET ANALYSIS BY PRODUCT FORMULATION
  204.   6.35 ITALY MARKET ANALYSIS BY END USER DEMOGRAPHICS
  205.   6.36 ITALY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  206.   6.37 ITALY MARKET ANALYSIS BY SKIN TYPE COMPATIBILITY
  207.   6.38 ITALY MARKET ANALYSIS BY FUNCTIONALITY
  208.   6.39 SPAIN MARKET ANALYSIS BY PRODUCT FORMULATION
  209.   6.40 SPAIN MARKET ANALYSIS BY END USER DEMOGRAPHICS
  210.   6.41 SPAIN MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  211.   6.42 SPAIN MARKET ANALYSIS BY SKIN TYPE COMPATIBILITY
  212.   6.43 SPAIN MARKET ANALYSIS BY FUNCTIONALITY
  213.   6.44 REST OF EUROPE MARKET ANALYSIS BY PRODUCT FORMULATION
  214.   6.45 REST OF EUROPE MARKET ANALYSIS BY END USER DEMOGRAPHICS
  215.   6.46 REST OF EUROPE MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  216.   6.47 REST OF EUROPE MARKET ANALYSIS BY SKIN TYPE COMPATIBILITY
  217.   6.48 REST OF EUROPE MARKET ANALYSIS BY FUNCTIONALITY
  218.   6.49 APAC MARKET ANALYSIS
  219.   6.50 CHINA MARKET ANALYSIS BY PRODUCT FORMULATION
  220.   6.51 CHINA MARKET ANALYSIS BY END USER DEMOGRAPHICS
  221.   6.52 CHINA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  222.   6.53 CHINA MARKET ANALYSIS BY SKIN TYPE COMPATIBILITY
  223.   6.54 CHINA MARKET ANALYSIS BY FUNCTIONALITY
  224.   6.55 INDIA MARKET ANALYSIS BY PRODUCT FORMULATION
  225.   6.56 INDIA MARKET ANALYSIS BY END USER DEMOGRAPHICS
  226.   6.57 INDIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  227.   6.58 INDIA MARKET ANALYSIS BY SKIN TYPE COMPATIBILITY
  228.   6.59 INDIA MARKET ANALYSIS BY FUNCTIONALITY
  229.   6.60 JAPAN MARKET ANALYSIS BY PRODUCT FORMULATION
  230.   6.61 JAPAN MARKET ANALYSIS BY END USER DEMOGRAPHICS
  231.   6.62 JAPAN MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  232.   6.63 JAPAN MARKET ANALYSIS BY SKIN TYPE COMPATIBILITY
  233.   6.64 JAPAN MARKET ANALYSIS BY FUNCTIONALITY
  234.   6.65 SOUTH KOREA MARKET ANALYSIS BY PRODUCT FORMULATION
  235.   6.66 SOUTH KOREA MARKET ANALYSIS BY END USER DEMOGRAPHICS
  236.   6.67 SOUTH KOREA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  237.   6.68 SOUTH KOREA MARKET ANALYSIS BY SKIN TYPE COMPATIBILITY
  238.   6.69 SOUTH KOREA MARKET ANALYSIS BY FUNCTIONALITY
  239.   6.70 MALAYSIA MARKET ANALYSIS BY PRODUCT FORMULATION
  240.   6.71 MALAYSIA MARKET ANALYSIS BY END USER DEMOGRAPHICS
  241.   6.72 MALAYSIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  242.   6.73 MALAYSIA MARKET ANALYSIS BY SKIN TYPE COMPATIBILITY
  243.   6.74 MALAYSIA MARKET ANALYSIS BY FUNCTIONALITY
  244.   6.75 THAILAND MARKET ANALYSIS BY PRODUCT FORMULATION
  245.   6.76 THAILAND MARKET ANALYSIS BY END USER DEMOGRAPHICS
  246.   6.77 THAILAND MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  247.   6.78 THAILAND MARKET ANALYSIS BY SKIN TYPE COMPATIBILITY
  248.   6.79 THAILAND MARKET ANALYSIS BY FUNCTIONALITY
  249.   6.80 INDONESIA MARKET ANALYSIS BY PRODUCT FORMULATION
  250.   6.81 INDONESIA MARKET ANALYSIS BY END USER DEMOGRAPHICS
  251.   6.82 INDONESIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  252.   6.83 INDONESIA MARKET ANALYSIS BY SKIN TYPE COMPATIBILITY
  253.   6.84 INDONESIA MARKET ANALYSIS BY FUNCTIONALITY
  254.   6.85 REST OF APAC MARKET ANALYSIS BY PRODUCT FORMULATION
  255.   6.86 REST OF APAC MARKET ANALYSIS BY END USER DEMOGRAPHICS
  256.   6.87 REST OF APAC MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  257.   6.88 REST OF APAC MARKET ANALYSIS BY SKIN TYPE COMPATIBILITY
  258.   6.89 REST OF APAC MARKET ANALYSIS BY FUNCTIONALITY
  259.   6.90 SOUTH AMERICA MARKET ANALYSIS
  260.   6.91 BRAZIL MARKET ANALYSIS BY PRODUCT FORMULATION
  261.   6.92 BRAZIL MARKET ANALYSIS BY END USER DEMOGRAPHICS
  262.   6.93 BRAZIL MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  263.   6.94 BRAZIL MARKET ANALYSIS BY SKIN TYPE COMPATIBILITY
  264.   6.95 BRAZIL MARKET ANALYSIS BY FUNCTIONALITY
  265.   6.96 MEXICO MARKET ANALYSIS BY PRODUCT FORMULATION
  266.   6.97 MEXICO MARKET ANALYSIS BY END USER DEMOGRAPHICS
  267.   6.98 MEXICO MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  268.   6.99 MEXICO MARKET ANALYSIS BY SKIN TYPE COMPATIBILITY
  269.   6.100 MEXICO MARKET ANALYSIS BY FUNCTIONALITY
  270.   6.101 ARGENTINA MARKET ANALYSIS BY PRODUCT FORMULATION
  271.   6.102 ARGENTINA MARKET ANALYSIS BY END USER DEMOGRAPHICS
  272.   6.103 ARGENTINA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  273.   6.104 ARGENTINA MARKET ANALYSIS BY SKIN TYPE COMPATIBILITY
  274.   6.105 ARGENTINA MARKET ANALYSIS BY FUNCTIONALITY
  275.   6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY PRODUCT FORMULATION
  276.   6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER DEMOGRAPHICS
  277.   6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  278.   6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY SKIN TYPE COMPATIBILITY
  279.   6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY FUNCTIONALITY
  280.   6.111 MEA MARKET ANALYSIS
  281.   6.112 GCC COUNTRIES MARKET ANALYSIS BY PRODUCT FORMULATION
  282.   6.113 GCC COUNTRIES MARKET ANALYSIS BY END USER DEMOGRAPHICS
  283.   6.114 GCC COUNTRIES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  284.   6.115 GCC COUNTRIES MARKET ANALYSIS BY SKIN TYPE COMPATIBILITY
  285.   6.116 GCC COUNTRIES MARKET ANALYSIS BY FUNCTIONALITY
  286.   6.117 SOUTH AFRICA MARKET ANALYSIS BY PRODUCT FORMULATION
  287.   6.118 SOUTH AFRICA MARKET ANALYSIS BY END USER DEMOGRAPHICS
  288.   6.119 SOUTH AFRICA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  289.   6.120 SOUTH AFRICA MARKET ANALYSIS BY SKIN TYPE COMPATIBILITY
  290.   6.121 SOUTH AFRICA MARKET ANALYSIS BY FUNCTIONALITY
  291.   6.122 REST OF MEA MARKET ANALYSIS BY PRODUCT FORMULATION
  292.   6.123 REST OF MEA MARKET ANALYSIS BY END USER DEMOGRAPHICS
  293.   6.124 REST OF MEA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  294.   6.125 REST OF MEA MARKET ANALYSIS BY SKIN TYPE COMPATIBILITY
  295.   6.126 REST OF MEA MARKET ANALYSIS BY FUNCTIONALITY
  296.   6.127 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
  297.   6.128 RESEARCH PROCESS OF MRFR
  298.   6.129 DRO ANALYSIS OF CHEMICALS AND MATERIALS
  299.   6.130 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
  300.   6.131 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
  301.   6.132 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
  302.   6.133 CHEMICALS AND MATERIALS, BY PRODUCT FORMULATION, 2024 (% SHARE)
  303.   6.134 CHEMICALS AND MATERIALS, BY PRODUCT FORMULATION, 2024 TO 2035 (USD Billion)
  304.   6.135 CHEMICALS AND MATERIALS, BY END USER DEMOGRAPHICS, 2024 (% SHARE)
  305.   6.136 CHEMICALS AND MATERIALS, BY END USER DEMOGRAPHICS, 2024 TO 2035 (USD Billion)
  306.   6.137 CHEMICALS AND MATERIALS, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
  307.   6.138 CHEMICALS AND MATERIALS, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Billion)
  308.   6.139 CHEMICALS AND MATERIALS, BY SKIN TYPE COMPATIBILITY, 2024 (% SHARE)
  309.   6.140 CHEMICALS AND MATERIALS, BY SKIN TYPE COMPATIBILITY, 2024 TO 2035 (USD Billion)
  310.   6.141 CHEMICALS AND MATERIALS, BY FUNCTIONALITY, 2024 (% SHARE)
  311.   6.142 CHEMICALS AND MATERIALS, BY FUNCTIONALITY, 2024 TO 2035 (USD Billion)
  312.   6.143 BENCHMARKING OF MAJOR COMPETITORS
  313. 7 LIST OF TABLES
  314.   7.1 LIST OF ASSUMPTIONS
  315.     7.1.1
  316.   7.2 North America MARKET SIZE ESTIMATES; FORECAST
  317.     7.2.1 BY PRODUCT FORMULATION, 2025-2035 (USD Billion)
  318.     7.2.2 BY END USER DEMOGRAPHICS, 2025-2035 (USD Billion)
  319.     7.2.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  320.     7.2.4 BY SKIN TYPE COMPATIBILITY, 2025-2035 (USD Billion)
  321.     7.2.5 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  322.   7.3 US MARKET SIZE ESTIMATES; FORECAST
  323.     7.3.1 BY PRODUCT FORMULATION, 2025-2035 (USD Billion)
  324.     7.3.2 BY END USER DEMOGRAPHICS, 2025-2035 (USD Billion)
  325.     7.3.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  326.     7.3.4 BY SKIN TYPE COMPATIBILITY, 2025-2035 (USD Billion)
  327.     7.3.5 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  328.   7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  329.     7.4.1 BY PRODUCT FORMULATION, 2025-2035 (USD Billion)
  330.     7.4.2 BY END USER DEMOGRAPHICS, 2025-2035 (USD Billion)
  331.     7.4.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  332.     7.4.4 BY SKIN TYPE COMPATIBILITY, 2025-2035 (USD Billion)
  333.     7.4.5 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  334.   7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  335.     7.5.1 BY PRODUCT FORMULATION, 2025-2035 (USD Billion)
  336.     7.5.2 BY END USER DEMOGRAPHICS, 2025-2035 (USD Billion)
  337.     7.5.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  338.     7.5.4 BY SKIN TYPE COMPATIBILITY, 2025-2035 (USD Billion)
  339.     7.5.5 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  340.   7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  341.     7.6.1 BY PRODUCT FORMULATION, 2025-2035 (USD Billion)
  342.     7.6.2 BY END USER DEMOGRAPHICS, 2025-2035 (USD Billion)
  343.     7.6.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  344.     7.6.4 BY SKIN TYPE COMPATIBILITY, 2025-2035 (USD Billion)
  345.     7.6.5 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  346.   7.7 UK MARKET SIZE ESTIMATES; FORECAST
  347.     7.7.1 BY PRODUCT FORMULATION, 2025-2035 (USD Billion)
  348.     7.7.2 BY END USER DEMOGRAPHICS, 2025-2035 (USD Billion)
  349.     7.7.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  350.     7.7.4 BY SKIN TYPE COMPATIBILITY, 2025-2035 (USD Billion)
  351.     7.7.5 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  352.   7.8 France MARKET SIZE ESTIMATES; FORECAST
  353.     7.8.1 BY PRODUCT FORMULATION, 2025-2035 (USD Billion)
  354.     7.8.2 BY END USER DEMOGRAPHICS, 2025-2035 (USD Billion)
  355.     7.8.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  356.     7.8.4 BY SKIN TYPE COMPATIBILITY, 2025-2035 (USD Billion)
  357.     7.8.5 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  358.   7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  359.     7.9.1 BY PRODUCT FORMULATION, 2025-2035 (USD Billion)
  360.     7.9.2 BY END USER DEMOGRAPHICS, 2025-2035 (USD Billion)
  361.     7.9.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  362.     7.9.4 BY SKIN TYPE COMPATIBILITY, 2025-2035 (USD Billion)
  363.     7.9.5 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  364.   7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  365.     7.10.1 BY PRODUCT FORMULATION, 2025-2035 (USD Billion)
  366.     7.10.2 BY END USER DEMOGRAPHICS, 2025-2035 (USD Billion)
  367.     7.10.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  368.     7.10.4 BY SKIN TYPE COMPATIBILITY, 2025-2035 (USD Billion)
  369.     7.10.5 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  370.   7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  371.     7.11.1 BY PRODUCT FORMULATION, 2025-2035 (USD Billion)
  372.     7.11.2 BY END USER DEMOGRAPHICS, 2025-2035 (USD Billion)
  373.     7.11.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  374.     7.11.4 BY SKIN TYPE COMPATIBILITY, 2025-2035 (USD Billion)
  375.     7.11.5 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  376.   7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  377.     7.12.1 BY PRODUCT FORMULATION, 2025-2035 (USD Billion)
  378.     7.12.2 BY END USER DEMOGRAPHICS, 2025-2035 (USD Billion)
  379.     7.12.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  380.     7.12.4 BY SKIN TYPE COMPATIBILITY, 2025-2035 (USD Billion)
  381.     7.12.5 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  382.   7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  383.     7.13.1 BY PRODUCT FORMULATION, 2025-2035 (USD Billion)
  384.     7.13.2 BY END USER DEMOGRAPHICS, 2025-2035 (USD Billion)
  385.     7.13.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  386.     7.13.4 BY SKIN TYPE COMPATIBILITY, 2025-2035 (USD Billion)
  387.     7.13.5 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  388.   7.14 China MARKET SIZE ESTIMATES; FORECAST
  389.     7.14.1 BY PRODUCT FORMULATION, 2025-2035 (USD Billion)
  390.     7.14.2 BY END USER DEMOGRAPHICS, 2025-2035 (USD Billion)
  391.     7.14.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  392.     7.14.4 BY SKIN TYPE COMPATIBILITY, 2025-2035 (USD Billion)
  393.     7.14.5 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  394.   7.15 India MARKET SIZE ESTIMATES; FORECAST
  395.     7.15.1 BY PRODUCT FORMULATION, 2025-2035 (USD Billion)
  396.     7.15.2 BY END USER DEMOGRAPHICS, 2025-2035 (USD Billion)
  397.     7.15.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  398.     7.15.4 BY SKIN TYPE COMPATIBILITY, 2025-2035 (USD Billion)
  399.     7.15.5 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  400.   7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  401.     7.16.1 BY PRODUCT FORMULATION, 2025-2035 (USD Billion)
  402.     7.16.2 BY END USER DEMOGRAPHICS, 2025-2035 (USD Billion)
  403.     7.16.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  404.     7.16.4 BY SKIN TYPE COMPATIBILITY, 2025-2035 (USD Billion)
  405.     7.16.5 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  406.   7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  407.     7.17.1 BY PRODUCT FORMULATION, 2025-2035 (USD Billion)
  408.     7.17.2 BY END USER DEMOGRAPHICS, 2025-2035 (USD Billion)
  409.     7.17.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  410.     7.17.4 BY SKIN TYPE COMPATIBILITY, 2025-2035 (USD Billion)
  411.     7.17.5 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  412.   7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  413.     7.18.1 BY PRODUCT FORMULATION, 2025-2035 (USD Billion)
  414.     7.18.2 BY END USER DEMOGRAPHICS, 2025-2035 (USD Billion)
  415.     7.18.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  416.     7.18.4 BY SKIN TYPE COMPATIBILITY, 2025-2035 (USD Billion)
  417.     7.18.5 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  418.   7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  419.     7.19.1 BY PRODUCT FORMULATION, 2025-2035 (USD Billion)
  420.     7.19.2 BY END USER DEMOGRAPHICS, 2025-2035 (USD Billion)
  421.     7.19.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  422.     7.19.4 BY SKIN TYPE COMPATIBILITY, 2025-2035 (USD Billion)
  423.     7.19.5 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  424.   7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  425.     7.20.1 BY PRODUCT FORMULATION, 2025-2035 (USD Billion)
  426.     7.20.2 BY END USER DEMOGRAPHICS, 2025-2035 (USD Billion)
  427.     7.20.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  428.     7.20.4 BY SKIN TYPE COMPATIBILITY, 2025-2035 (USD Billion)
  429.     7.20.5 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  430.   7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  431.     7.21.1 BY PRODUCT FORMULATION, 2025-2035 (USD Billion)
  432.     7.21.2 BY END USER DEMOGRAPHICS, 2025-2035 (USD Billion)
  433.     7.21.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  434.     7.21.4 BY SKIN TYPE COMPATIBILITY, 2025-2035 (USD Billion)
  435.     7.21.5 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  436.   7.22 South America MARKET SIZE ESTIMATES; FORECAST
  437.     7.22.1 BY PRODUCT FORMULATION, 2025-2035 (USD Billion)
  438.     7.22.2 BY END USER DEMOGRAPHICS, 2025-2035 (USD Billion)
  439.     7.22.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  440.     7.22.4 BY SKIN TYPE COMPATIBILITY, 2025-2035 (USD Billion)
  441.     7.22.5 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  442.   7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  443.     7.23.1 BY PRODUCT FORMULATION, 2025-2035 (USD Billion)
  444.     7.23.2 BY END USER DEMOGRAPHICS, 2025-2035 (USD Billion)
  445.     7.23.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  446.     7.23.4 BY SKIN TYPE COMPATIBILITY, 2025-2035 (USD Billion)
  447.     7.23.5 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  448.   7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  449.     7.24.1 BY PRODUCT FORMULATION, 2025-2035 (USD Billion)
  450.     7.24.2 BY END USER DEMOGRAPHICS, 2025-2035 (USD Billion)
  451.     7.24.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  452.     7.24.4 BY SKIN TYPE COMPATIBILITY, 2025-2035 (USD Billion)
  453.     7.24.5 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  454.   7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  455.     7.25.1 BY PRODUCT FORMULATION, 2025-2035 (USD Billion)
  456.     7.25.2 BY END USER DEMOGRAPHICS, 2025-2035 (USD Billion)
  457.     7.25.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  458.     7.25.4 BY SKIN TYPE COMPATIBILITY, 2025-2035 (USD Billion)
  459.     7.25.5 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  460.   7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  461.     7.26.1 BY PRODUCT FORMULATION, 2025-2035 (USD Billion)
  462.     7.26.2 BY END USER DEMOGRAPHICS, 2025-2035 (USD Billion)
  463.     7.26.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  464.     7.26.4 BY SKIN TYPE COMPATIBILITY, 2025-2035 (USD Billion)
  465.     7.26.5 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  466.   7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  467.     7.27.1 BY PRODUCT FORMULATION, 2025-2035 (USD Billion)
  468.     7.27.2 BY END USER DEMOGRAPHICS, 2025-2035 (USD Billion)
  469.     7.27.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  470.     7.27.4 BY SKIN TYPE COMPATIBILITY, 2025-2035 (USD Billion)
  471.     7.27.5 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  472.   7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  473.     7.28.1 BY PRODUCT FORMULATION, 2025-2035 (USD Billion)
  474.     7.28.2 BY END USER DEMOGRAPHICS, 2025-2035 (USD Billion)
  475.     7.28.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  476.     7.28.4 BY SKIN TYPE COMPATIBILITY, 2025-2035 (USD Billion)
  477.     7.28.5 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  478.   7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  479.     7.29.1 BY PRODUCT FORMULATION, 2025-2035 (USD Billion)
  480.     7.29.2 BY END USER DEMOGRAPHICS, 2025-2035 (USD Billion)
  481.     7.29.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  482.     7.29.4 BY SKIN TYPE COMPATIBILITY, 2025-2035 (USD Billion)
  483.     7.29.5 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  484.   7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  485.     7.30.1 BY PRODUCT FORMULATION, 2025-2035 (USD Billion)
  486.     7.30.2 BY END USER DEMOGRAPHICS, 2025-2035 (USD Billion)
  487.     7.30.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  488.     7.30.4 BY SKIN TYPE COMPATIBILITY, 2025-2035 (USD Billion)
  489.     7.30.5 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  490.   7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  491.     7.31.1
  492.   7.32 ACQUISITION/PARTNERSHIP
  493.     7.32.1

Chemicals and Materials Market Segmentation

Chemicals and Materials By Product Formulation (USD Billion, 2025-2035)

  • Sunscreens
  • Moisturizers
  • Makeup Products
  • Hair Care Products

Chemicals and Materials By End User Demographics (USD Billion, 2025-2035)

  • Adults
  • Children
  • Seniors

Chemicals and Materials By Distribution Channel (USD Billion, 2025-2035)

  • Online Retail
  • Pharmacy
  • Supermarkets
  • Specialty Stores

Chemicals and Materials By Skin Type Compatibility (USD Billion, 2025-2035)

  • Oily Skin
  • Dry Skin
  • Combination Skin
  • Sensitive Skin

Chemicals and Materials By Functionality (USD Billion, 2025-2035)

  • UV Protection
  • Anti-Aging
  • Hydration
  • Color Correction

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $ $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions